Gustavo A. Ortiz
Pilar, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting injury-induced transglutaminase-2 activity with a cementoin-SLPI fusion protein: a novel therapeutic strategy for alkali-induced corneal injury.
Journal: Journal of translational medicine
Published: February 23, 2026
Downregulation of the Transglutaminase 2-NF-κB Inflammatory Axis by a Fusion Protein of Cementoin and Secretory Leukocyte Protease Inhibitor Reduces Corneal Angiogenesis.
Journal: International journal of molecular sciences
Published: February 18, 2026
Inboard advance of arc magmatism regulates mountain building in the Andes.
Journal: Nature communications
Published: December 31, 2024
Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy.
Journal: PloS one
Published: September 20, 2019
Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina.
Journal: Experimental eye research
Published: February 27, 2018
Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2.
Journal: Current eye research
Published: December 22, 2017
Possible neuroprotective role of P2X2 in the retina of diabetic rats.
Journal: Diabetology & metabolic syndrome
Published: September 28, 2017
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Journal: Biological research
Published: July 28, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026